Sunitinib Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 12.5 mg, 25 mg, 37.5 mg, 50 mg

Reference Brands: Sutent® (EU & US)

Category: Oncology Cancer Care

Sunitinib is available in Tablet and strengths such as 12.5 mg, 25 mg, 37.5 mg, 50 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Sunitinib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Sunitinib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Sunitinib Tablets are oral tyrosine kinase inhibitors used to treat renal cell carcinoma, gastrointestinal stromal tumors, and pancreatic neuroendocrine tumors. Available in 12.5 mg, 25 mg, 37.5 mg, and 50 mg film-coated tablets, our products comply with EU-GMP and USFDA standards. Offered for B2B supply, contract manufacturing, and private labeling, Sunitinib comes with full regulatory documentation including CTD dossiers and bioequivalence data. Trusted by distributors and hospital pharmacies across the US and EU, these tablets ensure consistent quality and efficacy for oncology treatment programs in regulated markets.